The role of co-production in Learning Health Systems.

Learning Health System co-production health quality improvement health service research patient-centred care

Journal

International journal for quality in health care : journal of the International Society for Quality in Health Care
ISSN: 1464-3677
Titre abrégé: Int J Qual Health Care
Pays: England
ID NLM: 9434628

Informations de publication

Date de publication:
29 Nov 2021
Historique:
received: 11 01 2021
revised: 24 03 2021
accepted: 16 04 2021
entrez: 1 12 2021
pubmed: 2 12 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Co-production of health is defined as 'the interdependent work of users and professionals who are creating, designing, producing, delivering, assessing, and evaluating the relationships and actions that contribute to the health of individuals and populations'. It can assume many forms and include multiple stakeholders in pursuit of continuous improvement, as in Learning Health Systems (LHSs). There is increasing interest in how the LHS concept allows integration of different knowledge domains to support and achieve better health. Even if definitions of LHSs include engaging users and their family as active participants in aspects of enabling better health for individuals and populations, LHS descriptions emphasize technological solutions, such as the use of information systems. Fewer LHS texts address how interpersonal interactions contribute to the design and improvement of healthcare services. We examined the literature on LHS to clarify the role and contributions of co-production in LHS conceptualizations and applications. First, we undertook a scoping review of LHS conceptualizations. Second, we compared those conceptualizations to the characteristics of LHSs first described by the US Institute of Medicine. Third, we examined the LHS conceptualizations to assess how they bring four types of value co-creation in public services into play: co-production, co-design, co-construction and co-innovation. These were used to describe core ideas, as principles, to guide development. Among 17 identified LHS conceptualizations, 3 qualified as most comprehensive regarding fidelity to LHS characteristics and their use in multiple settings: (i) the Cincinnati Collaborative LHS Model, (ii) the Dartmouth Coproduction LHS Model and (iii) the Michigan Learning Cycle Model. These conceptualizations exhibit all four types of value co-creation, provide examples of how LHSs can harness co-production and are used to identify principles that can enhance value co-creation: (i) use a shared aim, (ii) navigate towards improved outcomes, (iii) tailor feedback with and for users, (iv) distribute leadership, (v) facilitate interactions, (vi) co-design services and (vii) support self-organization. The LHS conceptualizations have common features and harness co-production to generate value for individual patients as well as for health systems. They facilitate learning and improvement by integrating supportive technologies into the sociotechnical systems that make up healthcare. Further research on LHS applications in real-world complex settings is needed to unpack how LHSs are grown through coproduction and other types of value co-creation.

Sections du résumé

BACKGROUND BACKGROUND
Co-production of health is defined as 'the interdependent work of users and professionals who are creating, designing, producing, delivering, assessing, and evaluating the relationships and actions that contribute to the health of individuals and populations'. It can assume many forms and include multiple stakeholders in pursuit of continuous improvement, as in Learning Health Systems (LHSs). There is increasing interest in how the LHS concept allows integration of different knowledge domains to support and achieve better health. Even if definitions of LHSs include engaging users and their family as active participants in aspects of enabling better health for individuals and populations, LHS descriptions emphasize technological solutions, such as the use of information systems. Fewer LHS texts address how interpersonal interactions contribute to the design and improvement of healthcare services.
OBJECTIVE OBJECTIVE
We examined the literature on LHS to clarify the role and contributions of co-production in LHS conceptualizations and applications.
METHOD METHODS
First, we undertook a scoping review of LHS conceptualizations. Second, we compared those conceptualizations to the characteristics of LHSs first described by the US Institute of Medicine. Third, we examined the LHS conceptualizations to assess how they bring four types of value co-creation in public services into play: co-production, co-design, co-construction and co-innovation. These were used to describe core ideas, as principles, to guide development.
RESULT RESULTS
Among 17 identified LHS conceptualizations, 3 qualified as most comprehensive regarding fidelity to LHS characteristics and their use in multiple settings: (i) the Cincinnati Collaborative LHS Model, (ii) the Dartmouth Coproduction LHS Model and (iii) the Michigan Learning Cycle Model. These conceptualizations exhibit all four types of value co-creation, provide examples of how LHSs can harness co-production and are used to identify principles that can enhance value co-creation: (i) use a shared aim, (ii) navigate towards improved outcomes, (iii) tailor feedback with and for users, (iv) distribute leadership, (v) facilitate interactions, (vi) co-design services and (vii) support self-organization.
CONCLUSIONS CONCLUSIONS
The LHS conceptualizations have common features and harness co-production to generate value for individual patients as well as for health systems. They facilitate learning and improvement by integrating supportive technologies into the sociotechnical systems that make up healthcare. Further research on LHS applications in real-world complex settings is needed to unpack how LHSs are grown through coproduction and other types of value co-creation.

Identifiants

pubmed: 34849971
pii: 6445917
doi: 10.1093/intqhc/mzab072
pmc: PMC8849120
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

ii26-ii32

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of International Society for Quality in Health Care.

Références

Learn Health Syst. 2020 Feb 26;5(2):e10224
pubmed: 33889733
Learn Health Syst. 2020 Nov 12;5(4):e10252
pubmed: 34667875
BMJ Qual Saf. 2018 Nov;27(11):937-946
pubmed: 29438072
Learn Health Syst. 2020 Apr 06;5(2):e10225
pubmed: 33889734
Health Aff (Millwood). 2014 Jul;33(7):1171-7
pubmed: 25006143
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):602-6
pubmed: 24821737
Transl Pediatr. 2019 Jul;8(3):182-192
pubmed: 31413952
J Med Internet Res. 2020 Mar 19;22(3):e17026
pubmed: 32191214
Yearb Med Inform. 2017 Aug;26(1):16-23
pubmed: 28480469
Curr Opin Crit Care. 2014 Oct;20(5):566-72
pubmed: 25159475
JMIR Form Res. 2019 Mar 14;3(1):e9858
pubmed: 30869643
JMIR Res Protoc. 2013 Oct 29;2(2):e43
pubmed: 24168835
Learn Health Syst. 2018 Jun 21;2(3):e10059
pubmed: 31245587
J AHIMA. 2014 May;85(5):38-43
pubmed: 24938034
BMJ Qual Saf. 2020 Sep;29(9):711-716
pubmed: 31488570
BMJ. 2016 Jul 01;354:i3319
pubmed: 27370543
Int J Qual Health Care. 2019 Nov 30;31(9):721-724
pubmed: 30608587
Jt Comm J Qual Saf. 2003 Jan;29(1):5-15
pubmed: 12528569
Nephrology (Carlton). 2018 Oct;23 Suppl 4:112-115
pubmed: 30298659
Learn Health Syst. 2019 Dec 15;4(1):e10209
pubmed: 31989031
J Cyst Fibros. 2020 Sep;19(5):768-776
pubmed: 32354650
EGEMS (Wash DC). 2015 Aug 17;3(1):1168
pubmed: 26357665
Pediatrics. 2013 Jun;131 Suppl 4:S219-23
pubmed: 23729764
Learn Health Syst. 2019 Nov 13;4(1):e10205
pubmed: 31989029
JAMA Pediatr. 2014 Mar;168(3):201-2
pubmed: 24446048
J Gen Intern Med. 2012 Oct;27(10):1361-7
pubmed: 22618581
Am J Gastroenterol. 2017 Mar;112(3):406-408
pubmed: 28195179
JMIR Hum Factors. 2018 Feb 22;5(1):e8
pubmed: 29472173
Implement Sci. 2020 Mar 6;15(1):16
pubmed: 32143678
Med Care. 2019 May;57 Suppl 5 Suppl 1:S31-S37
pubmed: 30985594
J Palliat Med. 2018 Mar;21(S2):S61-S67
pubmed: 29091509
Pediatrics. 2012 Apr;129(4):e1030-41
pubmed: 22412030
JAMA. 2002 Oct 9;288(14):1775-9
pubmed: 12365965
J Clin Oncol. 2010 Sep 20;28(27):4268-74
pubmed: 20585094
Learn Health Syst. 2019 Dec 05;4(2):e10212
pubmed: 32313837
J Gen Intern Med. 2018 Dec;33(12):2237-2239
pubmed: 30155611

Auteurs

Andreas Gremyr (A)

Department of Schizophrenia Spectrum Disorders, Sahlgrenska University Hospital, Sahlgrenska Universitetssjukhuset Psykiatri Psykos, Göteborgsvägen 31, Mölndal, Västragötalandsregionen 431 80, Sweden.
Jönköping Academy for Improvement of Health and Welfare, School of Health and Welfare, Jönköping University, Barnarpsgatan 39, Jönköping, Jönköpings län 55111, Sweden.

Boel Andersson Gäre (B)

Jönköping Academy for Improvement of Health and Welfare, School of Health and Welfare, Jönköping University, Barnarpsgatan 39, Jönköping, Jönköpings län 55111, Sweden.

Johan Thor (J)

Geisel School of Medicine at Dartmouth, The Dartmouth Institute for Health Policy and Clinical Practice, Williamson Translational Research Building, Level 5, 1 Medical Center Drive, Lebanon, NH 03756, USA.

Glyn Elwyn (G)

Geisel School of Medicine at Dartmouth, The Dartmouth Institute for Health Policy and Clinical Practice, Williamson Translational Research Building, Level 5, 1 Medical Center Drive, Lebanon, NH 03756, USA.

Paul Batalden (P)

Jönköping Academy for Improvement of Health and Welfare, School of Health and Welfare, Jönköping University, Barnarpsgatan 39, Jönköping, Jönköpings län 55111, Sweden.
Geisel School of Medicine at Dartmouth, The Dartmouth Institute for Health Policy and Clinical Practice, Williamson Translational Research Building, Level 5, 1 Medical Center Drive, Lebanon, NH 03756, USA.

Ann-Christine Andersson (AC)

Jönköping Academy for Improvement of Health and Welfare, School of Health and Welfare, Jönköping University, Barnarpsgatan 39, Jönköping, Jönköpings län 55111, Sweden.
Department of Care Science, Malmö University, Nordenskiöldsgatan 1, Malmö, Skåne 211 19, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH